Skip to main content
Autobound logo
Emergent BioSolutions Inc.SEC 8-K

CFO Rich Lindahl to Retire December 31, 2026; Frank Vargo Named Interim CFO

Read at SEC EDGAR

What happened

2 signals in this filing. Emergent BioSolutions announced that Executive Vice President and Chief Financial Officer Rich Lindahl will retire effective December 31, 2026, with Vice President, Treasurer Frank Vargo serving as interim CFO...

Source

Extracted by Autobound

From the Signal API record
Signal
SEC 8-K

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Filed
Nov 2, 2026

More SEC 8-K signals at other companies

The full record

From the Signal API record

Details

CIK
1367644
Accession number
0001367644-26-000110
Timeframe
Next quarter
Filing year
2026
Fiscal year end
11/02
Why it matters
Budget/procurement review
Signal category
Leadership
Event
cfoChange

Topics and mentions

Events in the filing

  • Bookings decline
  • CFO change

Tags

  • bookingsDecline
  • cfoChange

Extraction

Confidence
High
Relevance
95%
Sentiment
Neutral
Detected
Nov 3, 2026
signal_type
sec-8k
signal_subtype
cfoChange

Use this data

Get every SEC 8-K signal for Emergent BioSolutions Inc. and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Emergent BioSolutions Inc. this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns SEC 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/5aee3123-2bc2-4a67-adbc-5bbcea3df235 returns this record as JSON. POST /v1/companies/enrich returns every signal for emergentbiosolutions.com.

{
  "signal_id": "5aee3123-2bc2-4a67-adbc-5bbcea3df235",
  "signal_type": "sec-8k",
  "signal_subtype": "cfoChange",
  "detected_at": "2026-11-03T07:12:27.891+00:00",
  "company": {
    "name": "Emergent BioSolutions Inc.",
    "domain": "emergentbiosolutions.com"
  },
  "data": {
    "detail": "Emergent BioSolutions announced that Executive Vice President and Chief Financial Officer Rich Lindahl will retire effective December 31, 2026, with Vice President, Treasurer Frank Vargo serving as interim CFO beginning January 1, 2027. Lindahl will remain as a part-time advisor through March 31, 2027, creating an opportunity for finance, accounting, and advisory vendors to engage the incoming finance leadership.",
    "metrics": {
      "timeframe": "next_quarter"
    },
    "summary": "CFO Rich Lindahl to Retire December 31, 2026; Frank Vargo Named Interim CFO",
    "relevance": 0.95,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1367644/000136764426000110/ebs-20261102.htm",
    "filing_date": "2026-11-02",
    "filing_year": 2026,
    "fiscal_year_end": "11/02",
    "sales_relevance": "Budget/procurement review",
    "signal_category": "leadership"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.